webinar register page

Webinar banner
The Future of Cardiovascular Disease Risk Assessment
Debate topic: Should population-based CVD risk assessment models make way for individualised risk prediction techniques?

Cardiovascular disease (CVD) is a leading cause of death worldwide and a major contributor to reduced quality of life. Clinical decision making for the detection, management and prevention of CVD relies on accurate risk assessment. Local and international guidelines currently advocate for measurement of traditional CVD risk factors with use of a validated risk prediction tool. However, the realisation that traditional risk factors may not identify all those at risk of CVD has fueled a growing interest in the use of novel imaging techniques, clinical biomarkers and genetics to augment traditional risk assessment.

To celebrate World Heart Day, the Heart Foundation of Australia and World Heart Federation invites you to join us for a global clinical debate on the future of CVD risk assessment.

This webinar will be chaired by Prof Garry Jennings, Chief Medical Advisor, Heart Foundation of Australia.

This event is sponsored by Servier through an independent education grant. All content was developed independently.

Sep 29, 2020 08:30 PM in Canberra, Melbourne, Sydney

Webinar logo
* Required information
Loading

Speakers

Donald Lloyd-Jones
Professor @Northwestern University
Donald is among the world’s most highly regarded experts in cardiovascular disease prevention and epidemiology. He is currently the Chair of the Department of Preventive Medicine and the Eileen M. Foell Professor of Heart Research and Professor of Preventive Medicine, Medicine-Cardiology, and Paediatrics at Northwestern University in Chicago. A major focus of his research has been the investigation of lifetime risks for various cardiovascular diseases and risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology of hypertension. As a cardiology fellow at the Massachusetts General Hospital he completed his research fellowship at the Framingham Heart Study. Donald has authored more than 350 peer-reviewed articles and co-chaired the expert group that created the 2013 American College of Cardiology/American Heart Association Guideline on the Assessment of Cardiovascular Risk. He is currently the President-elect of the American Heart Association.
Stephen Nicholls
Professor @Monash University
Steve Nicholls is the Director of MonashHeart, Director of Victorian Heart Institute and Professor of Cardiology at Monash University. He will be the Director of the Victorian Heart Hospital. He completed his cardiology training at John Hunter Hospital and PhD at the University of Adelaide, prior to holding a postdoctoral fellowship and faculty appointment at the Cleveland Clinic and the South Australian Health and Medical Research Institute. His research interests focus on the role of metabolic risk factors and imaging in atherosclerosis, with work spanning from early discovery to leadership of large clinical trials. He is Chair of the Australian Atherosclerosis Society Clinical Council, Australia and New Zealand Alliance for Cardiovascular Trials, Asia Pacific Cardiometabolic Consortium, Secretary of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.
Gemma Figtree
Professor @University of Sydney
Inspired by her clinical work as an interventional cardiologist, Gemma is committed to improving cardiovascular disease outcomes using her knowledge of molecular and cellular biology to develop novel therapies to prevent and treat events. She co-leads the Cardiovascular Theme for Sydney Health Partners, a NHMRC Advanced Health Research and Translation Centre and is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Her clinical leadership is recognised by her membership of the Scientific Board of Cardiac Society of Australia and New Zealand, appointment to the Expert Advisory Panel for NHMRC Structural Review of Grants Program (2016-17), and as Chair of the Heart Foundation’s Clinical Committee. She is committed to the promotion and advocacy of cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health.